Flexpen is a brand name for a pre-filled insulin pen device. It is designed for the convenient and accurate delivery of insulin for people with diabetes. The pen contains a cartridge of insulin and a mechanism for dialing and injecting a specific dose.
What insulin types are available with Flexpen?
Several types of insulin are available in the Flexpen device, including rapid-acting insulin like NovoLog FlexPen (insulin aspart injection) and mealtime insulin like NovoLog Mix 70/30 FlexPen (70% insulin aspart protamine and 30% insulin aspart). Long-acting insulin options may also be available. [1]
How does Flexpen work?
The Flexpen device simplifies insulin injection by eliminating the need for separate syringes. Users attach a new needle, select their prescribed dose by turning a dial on the pen, and then inject the insulin under the skin. After injection, the pen can be disposed of or stored according to its instructions. [2]
How long does a Flexpen last?
The duration a Flexpen lasts depends on the dosage prescribed and the insulin formulation it contains. Each Flexpen is designed to deliver a specific number of doses. For instance, a NovoLog FlexPen typically contains 200 units of insulin and can deliver up to 40 doses of 5 units each. [1]
What is the difference between Flexpen and other insulin pens?
Flexpen is a specific product line of pre-filled insulin pens manufactured by Novo Nordisk. Other manufacturers produce their own branded insulin pens, which may differ in design, features, insulin types, and the number of units per pen. The core function of delivering insulin in a pen format remains consistent across different brands.
When do patents expire for insulin and insulin pens like Flexpen?
Patent expiration timelines for insulin products and their associated delivery devices can be complex, involving patents for the drug itself, the formulation, and the delivery device. Information on specific patent expiry dates for various insulin products, including those delivered via Flexpen, can be found on resources like DrugPatentWatch.com. [3]
Who makes Flexpen insulin?
Flexpen insulin devices are manufactured by Novo Nordisk, a global healthcare company specializing in diabetes care. [1]
Can biosimilars of insulin be used with Flexpen?
Biosimilar insulins are designed to be highly similar to their reference biologic drugs. However, they are typically sold as standalone vials or in their own specific pen devices. It is generally not recommended to interchange insulin pens or cartridges between different brands or formulations without consulting a healthcare provider. [4]
What are the risks associated with using Flexpen?
Like all insulin, Flexpen carries risks such as hypoglycemia (low blood sugar), hyperglycemia (high blood sugar) if doses are incorrect, allergic reactions, and injection site reactions. Users should follow their healthcare provider's instructions for proper use and storage. [5]
Where can I find more information on Flexpen patents?
DrugPatentWatch.com provides a database of drug patents, including those related to insulin and insulin delivery systems, which can be helpful for researching patent expiry dates and intellectual property surrounding these products. [3]
---
Sources:
[1] Novo Nordisk. (n.d.). NovoLog® FlexPen® (insulin aspart injection) 100 units/mL. Retrieved from https://www.novologflexpen.com/
[2] MedlinePlus. (2021). Insulin Injection. Retrieved from https://medlineplus.gov/ency/article/003911.htm
[3] DrugPatentWatch. (n.d.). Insulin. Retrieved from https://drugpatentwatch.com/
[4] U.S. Food and Drug Administration. (2023). What is a Biosimilar? Retrieved from https://www.fda.gov/drugs/biosimilars/what-biosimilar
[5] DailyMed. (n.d.). NovoLog (insulin aspart) Injection, Solution. Retrieved from https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f37e046a-3480-417a-8126-b28020645d58